S100B

S100B

S100B 詳細

Molecule Name
Protein Nef
分子の別称
S100B,NEF,S100,S100beta
Drug Development Progress
治験薬の数1
市販薬剤の数0
研究&開発段階Phase 1 Clinical
ターゲットの別称
nef,Negative factor,3'ORF,Protein Nef,F-protein
バックグランド
S-100 protein beta chain (S100B),a member of the S-100 family, is also known as S-100 protein subunit beta and S100 calcium-binding protein B, which contains two EF-hand domains. S100B can weakly bind calcium but bind zinc very tightly-distinct binding sites with different affinities exist for both ions on each monomer. Also, S100B can bind to and initiate the activation of STK38 by releasing autoinhibitory intramolecular interactions within the kinase. Interaction with AGER after myocardial infarction,S100B may play a role in myocyte apoptosis by activating ERK1/2 and p53/TP53 signaling. Fuethermore,S100B could assist ATAD3A cytoplasmic processing, preventing aggregation and favoring mitochondrial localization. S100B may mediate calcium-dependent regulation on many physiological processes by interacting with other proteins, such as TPR-containing proteins, and modulating their activity.

S100B 製品リスト

Species
  • Human(1)
Tag
  • His Tag(1)
Host
  • E. coli(1)
Conjugate
  • Unconjugated(1)
Grade
  • RUO(1)
Low Endotoxin
  • No(1)
MoleculeCat. No.Product Name種HostStructurePurityActivitySize&Price
S100B
Human S100B Protein, His Tag
Human
E. coli
SDS-PAGE

$260.00

100ug
You Have Viewed 1-1 Of 1 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
HIV clade B mRNA dendritic cell therapy (Immunomic Therapeutics/Universite Libre de Bruxelles)Phase 1 ClinicalImmunomic Therapeutics Inc
HIV Infections
詳細
Customer Reviews